William K. Hagmann
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)
Publications by Year
Research Areas
Peptidase Inhibition and Analysis, Cell Adhesion Molecules Research, Protease and Inhibitor Mechanisms, Cannabis and Cannabinoid Research, Receptor Mechanisms and Signaling
Most-Cited Works
- → The Many Roles for Fluorine in Medicinal Chemistry(2008)3,517 cited
- → [18F]MK-9470, a positron emission tomography (PET) tracer forin vivohuman PET brain imaging of the cannabinoid-1 receptor(2007)313 cited
- → Stromelysin‐1: Three‐dimensional structure of the inhibited catalytic domain and of the C‐truncated proenzyme(1995)293 cited
- → Potent, orally absorbed glucagon receptor antagonists(1999)169 cited
- → Cephalosporin antibiotics can be modified to inhibit human leukocyte elastase(1986)166 cited
- → The NMR structure of the inhibited catalytic domain of human stromelysin–1(1994)154 cited
- → Discovery of N-[(1S,2S)-3-(4-Chlorophenyl)-2- (3-cyanophenyl)-1-methylpropyl]-2-methyl-2- {[5-(trifluoromethyl)pyridin-2-yl]oxy}propanamide (MK-0364), a Novel, Acyclic Cannabinoid-1 Receptor Inverse Agonist for the Treatment of Obesity